Business Wire

LTIMindtree’s FY25 Revenue up 7% in INR

23.4.2025 16:42:00 CEST | Business Wire | Press Release

Share

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended Mar 31, 2025, as approved by its Board of Directors.

“We concluded FY25 with a revenue growth of 5% in constant currency terms and an EBIT margin of 14.5%. Our key verticals and a major geography drove our yearly growth despite an ongoing challenging macro environment. The robust order inflow, driven by a significant array of AI-led deal wins, illustrates the pervasive integration of AI across our service offerings.

Venu Lambu’s transition to LTIMindtree has been seamless and supports our strategic goals. His growing understanding of the organisation, combined with our ability to secure large deals, strong presence in tech-intensive sectors, and robust balance sheet, positions us well to leverage the opportunities ahead of us.”
- Debashis Chatterjee, Chief Executive Officer and Managing Director

Key financial highlights:

Quarter ended Mar 31, 2025

In USD:

- Revenue at $1,131.0 million (-0.7% Q-o-Q / +5.8% Y-o-Y)
- Operating Margin (EBIT) at 13.8%
- Net profit at $130.6 million (+2.0% Q-o-Q / -1.4% Y-o-Y)

In INR:

- Revenue at Rs. 97,717 million (+1.1% Q-o-Q / +9.9% Y-o-Y)
- Net profit at Rs. 11,286 million (+3.9% Q-o-Q / +2.5% Y-o-Y)

Year ended Mar 31, 2025

In USD:

- Revenue at $4,492.5 million (+4.8% Y-o-Y)
- Operating Margin (EBIT) at 14.5%
- Net profit at $543.9 million (-1.7% Y-o-Y)

In INR:

- Revenue at Rs. 3,80,081 million (+7.0% Y-o-Y)
- Net profit at Rs. 46,020 million (+0.4% Y-o-Y)

Other highlights:

Clients:

- 741 active clients as of Mar 31, 2025
- $5 million+ clients increased by 1 on a Y-o-Y basis, total 154
- $50 million+ clients increased by 1 on a Y-o-Y basis, total 14

People:

- 84,307 professionals as of Mar 31, 2025
- Trailing 12 months attrition was 14.4%

Deal Wins

  • A leading US life insurance company has engaged LTIMindtree to enhance its quality processes using AI to improve the operating model, thereby advancing enterprise quality engineering maturity. This is a multi-year deal which will focus on enhancing quality engineering practices and leveraging AI to transform the operating model.
  • LTIMindtree has been selected by a global Energy major to provide NextGen ERP Support services across multiple functional and SaaS-based solutions.
  • A leading global financial institution has chosen LTIMindtree for its Data Center Migration Project. The deal encompasses the development of comprehensive infrastructure designs and architecture aimed at maximizing performance while minimizing the total cost of operations.
  • LTIMindtree secured an Application Managed Services deal from a leading North American utility company. LTIMindtree’s business-first approach will help the customer achieve quality at scale while improving cost efficiency and productivity.
  • LTIMindtree was chosen by a global reinsurance group to enhance efficiency through an AI Ops model as part of its end-to-end outsourcing deal.
  • A prominent life sciences company in North America has chosen LTIMindtree to undertake its Oracle implementation and maintenance project, ensuring an optimal delivery mix.
  • A leading US materials and construction company has engaged LTIMindtree to maintain and support its complex legacy ERP system as part of its digital transformation initiative.
  • A leading digital company in the KSA region has entrusted LTIMindtree with providing end-to-end operations services for their hybrid cloud security platform.

Partnerships

  • LTIMindtree and Google announced a Strategic Partnership to drive Business Transformation with Agentic AI. LTIMindtree will leverage offerings powered by Google Cloud technology using Agentic AI to redefine the cloud landscape for clients worldwide and drive broad-based GenAI adoption.
  • LTIMindtree has successfully achieved revalidation as an AWS Managed Services Provider (MSP) for the year 2024. The AWS MSP program is a worldwide initiative by AWS that recognizes and showcases the most proficient cloud partners with a demonstrated history and expertise in delivering comprehensive AWS solutions.
  • LTIMindtree has been recognized as the "Highest Overall SAP Qualified Pipeline" partner in the SI category at the AWS Champions Club UKI, marking our second consecutive win following our previous success in GenAI. This recognition underscores our strong momentum in SAP on AWS, leveraging both "RISE with SAP" and AWS-native customer journeys.
  • LTIMindtree is now accredited in the Salesforce Tableau Alliance, enabling dedicated resources for collaboration and a focus on joint Tableau customers. This partnership also grants early access to beta versions of products, coinciding with Salesforce's launch of the updated Tableau Next product suite, which is integrated into the Data Cloud.
  • LTIMindtree was awarded the Global Innovation Partner of the Year by Informatica, a significant accomplishment in our inaugural year as a GSI Partner. This honour reflects the strength of our collaboration with Informatica and our mutual commitment to advancing Data & AI transformation for our clients.

Recognitions

  • LTIMindtree recognized as a Strong Performer in Forrester’s 'The Modern Application Development Services Wave, Q1 2025.’
  • LTIMindtree recognized as a Contender in Forrester’s 'The Application Modernization and Multicloud Managed Services Wave, Q1 2025.’
  • LTIMindtree recognized as an Enterprise Innovator in HFS Horizon’s ‘The Salesforce Service Providers, 2025.’
  • LTIMindtree recognized as an Enterprise Innovator in HFS Horizon’s ‘The Generative Enterprise Services, 2025.’
  • LTIMindtree recognized as a Major Contender in Everest Group’s ‘SAP Business Application Services PEAK Matrix® Assessment 2025.’
  • LTIMindtree recognized as a Major Contender in Everest Group’s ‘Industry 4.0 Services PEAK Matrix® Assessment 2025.’
  • LTIMindtree positioned as a Leader in ISG’s Provider Lens™ evaluation for Oracle Cloud and Technology Ecosystem 2024 across all quadrants, US and Europe.

Announcements

The Board of Directors has recommended a final dividend of Rs. 45 per equity share of par value Rs. 1 each for the financial year ended March 31, 2025.

About LTIMindtree

LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 84,000+ talented and entrepreneurial professionals across more than 40 countries, LTIMindtree — a Larsen & Toubro Group company — solves the most complex business challenges and delivers transformation at scale. For more information, please visit https://www.ltimindtree.com/.

Earnings Conference Call

Universal Dial-in

+91 22 6280 1157

+91 22 7115 8058

International Toll Free

USA

UK

Singapore

Hong Kong

: 18667462133

: 08081011573

: 8001012045

: 800964448

Replay of Conference Call

Available after 1 hour from the call end time until Apr 24th, 2025

Playback Code: 51903

Dial-in Number: India +91 22 71945757

Audio Webcast

The audio from the conference call will be available online through a webcast and can be accessed at the following link: Click here for Audio Webcast

Click here for your DiamondPass™

DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.

If you have a DiamondPass™, click the above link to associate your pin and receive the access details for this conference. If you do not have a DiamondPass™, please register through the link and you will receive your DiamondPass™ for this conference.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250423101232/en/

Contacts

Media Relations Contact:shambhavi.revandkar@ltimindtree.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye